Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

LARIO THERAPEUTICS LIMITED

Company number SC716204

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
14 Jul 2024 AP01 Appointment of Dr Peter Michael Finan as a director on 9 July 2024
14 Jul 2024 TM01 Termination of appointment of Andrew Sinclair Dunlop as a director on 9 July 2024
03 Apr 2024 AA Accounts for a small company made up to 31 December 2023
11 Feb 2024 AP01 Appointment of Dr Chiara Rossana Maria Liberati as a director on 1 June 2023
11 Feb 2024 TM01 Termination of appointment of Stefan Lohmer as a director on 1 June 2023
15 Jan 2024 CS01 Confirmation statement made on 25 November 2023 with updates
17 Nov 2023 AA Accounts for a small company made up to 31 December 2022
31 Oct 2023 DISS40 Compulsory strike-off action has been discontinued
24 Oct 2023 GAZ1 First Gazette notice for compulsory strike-off
30 Jun 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
09 Jun 2023 RP04CS01 Second filing of Confirmation Statement dated 25 November 2022
07 Dec 2022 CS01 Confirmation statement made on 25 November 2022 with updates
  • ANNOTATION Second Filing The information on the form CS01 has been replaced by a second filing on 09/06/2023
15 Sep 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
12 Jul 2022 PSC02 Notification of Epidarex Capital Iii Uk, Lp as a person with significant control on 28 March 2022
12 Jul 2022 PSC07 Cessation of Henning Steinhagen as a person with significant control on 25 March 2022
14 Apr 2022 SH02 Sub-division of shares on 25 March 2022
13 Apr 2022 SH08 Change of share class name or designation
13 Apr 2022 SH10 Particulars of variation of rights attached to shares
13 Apr 2022 SH01 Statement of capital following an allotment of shares on 1 April 2022
  • GBP 215.052
08 Apr 2022 MA Memorandum and Articles of Association
08 Apr 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES12 ‐ Resolution of varying share rights or name
  • RES13 ‐ Shares sub-divided 25/03/2022
  • RES01 ‐ Resolution of adoption of Articles of Association
08 Apr 2022 AP01 Appointment of Mr Andrew Sinclair Dunlop as a director on 25 March 2022
07 Apr 2022 AA01 Current accounting period extended from 30 November 2022 to 31 December 2022
07 Apr 2022 AP01 Appointment of Dr Stefan Lohmer as a director on 25 March 2022
26 Nov 2021 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2021-11-26
  • GBP 11